Literature DB >> 25611315

The Trojan Lifetime Champions Health Survey: development, validity, and reliability.

Shawn C Sorenson1, Russell Romano, Robin M Scholefield, E Todd Schroeder, Stanley P Azen, George J Salem.   

Abstract

CONTEXT: Self-report questionnaires are an important method of evaluating lifespan health, exercise, and health-related quality of life (HRQL) outcomes among elite, competitive athletes. Few instruments, however, have undergone formal characterization of their psychometric properties within this population.
OBJECTIVE: To evaluate the validity and reliability of a novel health and exercise questionnaire, the Trojan Lifetime Champions (TLC) Health Survey.
DESIGN: Descriptive laboratory study.
SETTING: A large National Collegiate Athletic Association Division I university. PATIENTS OR OTHER PARTICIPANTS: A total of 63 university alumni (age range, 24 to 84 years), including former varsity collegiate athletes and a control group of nonathletes. INTERVENTION(S): Participants completed the TLC Health Survey twice at a mean interval of 23 days with randomization to the paper or electronic version of the instrument. MAIN OUTCOME MEASURE(S): Content validity, feasibility of administration, test-retest reliability, parallel-form reliability between paper and electronic forms, and estimates of systematic and typical error versus differences of clinical interest were assessed across a broad range of health, exercise, and HRQL measures.
RESULTS: Correlation coefficients, including intraclass correlation coefficients (ICCs) for continuous variables and κ agreement statistics for ordinal variables, for test-retest reliability averaged 0.86, 0.90, 0.80, and 0.74 for HRQL, lifetime health, recent health, and exercise variables, respectively. Correlation coefficients, again ICCs and κ, for parallel-form reliability (ie, equivalence) between paper and electronic versions averaged 0.90, 0.85, 0.85, and 0.81 for HRQL, lifetime health, recent health, and exercise variables, respectively. Typical measurement error was less than the a priori thresholds of clinical interest, and we found minimal evidence of systematic test-retest error. We found strong evidence of content validity, convergent construct validity with the Short-Form 12 Version 2 HRQL instrument, and feasibility of administration in an elite, competitive athletic population.
CONCLUSIONS: These data suggest that the TLC Health Survey is a valid and reliable instrument for assessing lifetime and recent health, exercise, and HRQL, among elite competitive athletes. Generalizability of the instrument may be enhanced by additional, larger-scale studies in diverse populations.

Entities:  

Keywords:  athletes; exercise; quality of life; questionnaires; reproducibility of results

Mesh:

Year:  2015        PMID: 25611315      PMCID: PMC4560004          DOI: 10.4085/1062-6050-50.2.10

Source DB:  PubMed          Journal:  J Athl Train        ISSN: 1062-6050            Impact factor:   2.860


  25 in total

1.  Reliability and validity of the SF-12 health survey among people with severe mental illness.

Authors:  M P Salyers; H B Bosworth; J W Swanson; J Lamb-Pagone; F C Osher
Journal:  Med Care       Date:  2000-11       Impact factor: 2.983

2.  Long term health impact of playing professional football in the United Kingdom.

Authors:  A P Turner; J H Barlow; C Heathcote-Elliott
Journal:  Br J Sports Med       Date:  2000-10       Impact factor: 13.800

3.  The management of muscle strain injuries: an early return versus the risk of recurrence.

Authors:  John Orchard; Thomas M Best
Journal:  Clin J Sport Med       Date:  2002-01       Impact factor: 3.638

Review 4.  Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

Authors:  G Samsa; D Edelman; M L Rothman; G R Williams; J Lipscomb; D Matchar
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

Review 5.  Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM.

Authors:  Joseph P Weir
Journal:  J Strength Cond Res       Date:  2005-02       Impact factor: 3.775

Review 6.  Sports career-related musculoskeletal injuries: long-term health effects on former athletes.

Authors:  Urho Kujala; Sakari Orava; Jari Parkkari; Jaakko Kaprio; Seppo Sarna
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

7.  Quality of life assessment in elite collegiate athletes.

Authors:  D R McAllister; A R Motamedi; S L Hame; M S Shapiro; F J Dorey
Journal:  Am J Sports Med       Date:  2001 Nov-Dec       Impact factor: 6.202

8.  Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis.

Authors:  N P Hurst; D A Ruta; P Kind
Journal:  Br J Rheumatol       Date:  1998-08

9.  Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.

Authors:  William L Haskell; I-Min Lee; Russell R Pate; Kenneth E Powell; Steven N Blair; Barry A Franklin; Caroline A Macera; Gregory W Heath; Paul D Thompson; Adrian Bauman
Journal:  Med Sci Sports Exerc       Date:  2007-08       Impact factor: 5.411

10.  Test-retest reliability of a self-administered musculoskeletal symptoms and job factors questionnaire used in ergonomics research.

Authors:  John C Rosecrance; Kelly J Ketchen; Linda A Merlino; Dan C Anton; Tom M Cook
Journal:  Appl Occup Environ Hyg       Date:  2002-09
View more
  2 in total

1.  Holistic life-span health outcomes among elite intercollegiate student-athletes.

Authors:  Shawn C Sorenson; Russell Romano; Robin M Scholefield; Brandon E Martin; James E Gordon; Stanley P Azen; E Todd Schroeder; George J Salem
Journal:  J Athl Train       Date:  2014-08-12       Impact factor: 2.860

2.  Life span exercise among elite intercollegiate student athletes.

Authors:  Shawn C Sorenson; Russell Romano; Stanley P Azen; E Todd Schroeder; George J Salem
Journal:  Sports Health       Date:  2015-01       Impact factor: 3.843

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.